BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 136345)

  • 1. Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma.
    Collen D
    Eur J Biochem; 1976 Oct; 69(1):209-16. PubMed ID: 136345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
    Müllertz S
    Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.
    Moroi M; Aoki N
    J Biol Chem; 1976 Oct; 251(19):5956-65. PubMed ID: 134998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay.
    Harpel PC
    J Clin Invest; 1981 Jul; 68(1):46-55. PubMed ID: 6166634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The primary inhibitor of plasmin in human plasma.
    Müllertz S; Clemmensen I
    Biochem J; 1976 Dec; 159(3):545-53. PubMed ID: 137718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The behavior of alpha2-plasmin inhibitor in fibrinolytic states.
    Aoki N; Moroi M; Matsuda M; Tachiya K
    J Clin Invest; 1977 Aug; 60(2):361-9. PubMed ID: 68962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
    Müllertz S; Thorsen S; Sottrup-Jensen L
    Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction in human plasma of antiplasmin, the fast-reacting plasmin inhibitor, with plasmin, thrombin, trypsin and chymotrypsin.
    Edy J; Collen D
    Biochim Biophys Acta; 1977 Oct; 484(2):423-32. PubMed ID: 143966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catabolic pathways for streptokinase, plasmin, and streptokinase activator complex in mice. In vivo reaction of plasminogen activator with alpha 2-macroglobulin.
    Gonias SL; Einarsson M; Pizzo SV
    J Clin Invest; 1982 Aug; 70(2):412-23. PubMed ID: 6178757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of human fibrinogen by plasms alpha2-macroglobulin-enzyme complexes.
    Harpel PC; Mosesson MW
    J Clin Invest; 1973 Sep; 52(9):2175-84. PubMed ID: 4269529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
    Thorsen S; Müllertz S; Suenson E; Kok P
    Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of plasma protease inhibitors to antiplasmin activity in man.
    Crawford GP; Ogston D; Douglas AS
    Clin Sci Mol Med; 1976 Aug; 51(2):215-8. PubMed ID: 60190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of streptokinase-human plasmin complex by the plasma proteinase inhibitors alpha 2-antiplasmin and alpha 2-macroglobulin is species specific and temperature dependent.
    Gonias SL; Figler NL; Braud LL
    Blood; 1988 Nov; 72(5):1658-64. PubMed ID: 2460159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of the modified form of human plasminogen by alpha 2-macroglobulin-plasmin complexes.
    Yamamoto J; Okamoto U; Morita S; Asada N; Yamaoka M
    Jpn J Physiol; 1985; 35(6):1013-21. PubMed ID: 2422420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of urokinase by complex formation with human alpha1-antitrypsin.
    Clemmensen I; Christensen F
    Biochim Biophys Acta; 1976 Apr; 429(2):591-9. PubMed ID: 1083251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of plasmin and its complexes with alpha 2-antiplasmin and alpha 2-macroglobulin on secretion of proteinase and plasminogen inhibitors from peripheral mononuclear cells].
    Zhabin SG; Zorin NA; Musatov MI
    Vopr Med Khim; 1995; 41(3):34-7. PubMed ID: 8585176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of plasmin autodigestion by human plasma alpha2-macroglobulin.
    Toki N; Ishihara H; Yamura T
    Scand J Haematol; 1977 Sep; 19(3):281-6. PubMed ID: 71756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the esterase and human plasminogen activator activities of various activated forms of human plasminogen and their equimolar streptokinase complexes.
    Wohl RC; Arzadon L; Summaria L; Robbins KC
    J Biol Chem; 1977 Feb; 252(4):1141-7. PubMed ID: 851483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of plasmin activity, plasminogen levels and activity of antiplasmins during endotoxin shock in dogs.
    Aasen AO; Gallimore MJ; Ohlsson K; Amundsen E
    Haemostasis; 1978; 7(2-3):164-9. PubMed ID: 77807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin.
    Clemmensen I; Petersen LC; Kluft C
    Eur J Biochem; 1986 Apr; 156(2):327-33. PubMed ID: 3009181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.